Objetivo
Most biopharmaceuticals (BP) currently on the market are recombinant proteins which are parenterally administered. These would benefit from more patient-friendly routes of administration. Moreover, new classes of BP (e.g. siRNA, miRNA, DARPins) with specificity for intracellular targets hold promise but await the advent of efficient delivery systems before their potential can be realised into therapeutic products. Solving the bottleneck of BP delivery is one of the main incentives of the pharmaceutical industry as this would allow a broadening of the spectrum of potential targets for therapeutic intervention needed to fill their drug pipelines. COMPACT represents Europe’s frontrunners in pharmaceutics, nanotechnology, biology, chemistry, engineering and imaging who will work in close collaboration with EFPIA on the delivery issues with BP. The main objectives are (1) to identify and understand transport pathways across biological barriers and cell membranes that can be utilized for delivery of BP, (2) to construct, characterise and preclincally validate BP formulations for non-invasive delivery of BP, with an emphasis on oral, airway and (trans)dermal delivery and for transport over the BBB. This will be achieved by setting up sophisticated in vitro models of biological barriers and appropriate animal models to find pathways that can be used for effective delivery of BP. In parallel, we will alter the BP either by chemical or biological engineering or by nano-formulations to enhance their uptake or transport over biological barriers.To be able to follow the transport,advanced imaging techniques will be utilised. The unique feature of this consortium is the alliance of experts in different research fields that complement each other in this challenging task. It is only the concerted action of such an interdisciplinary consortium that can make a difference in finding constructive solutions to the problem of poor bioavailability and target accessibility of BP.
Ámbito científico
Convocatoria de propuestas
IMI-JU-04-2011
Consulte otros proyectos de esta convocatoria
Régimen de financiación
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinador
65929 Frankfurt Am Main
Alemania
Ver en el mapa
Participantes (21)
3584 CS Utrecht
Ver en el mapa
1165 Kobenhavn
Ver en el mapa
38124 Braunschweig
Ver en el mapa
CF24 0DE Cardiff
Ver en el mapa
10691 Stockholm
Ver en el mapa
7491 Trondheim
Ver en el mapa
1010 Wien
Ver en el mapa
80539 Muenchen
Ver en el mapa
8006 Zurich
Ver en el mapa
9000 Gent
Ver en el mapa
6726 Szeged
Ver en el mapa
2970 Hoersholm
Ver en el mapa
00014 Helsingin Yliopisto
Ver en el mapa
2311 EZ Leiden
Ver en el mapa
OX1 2JD Oxford
Ver en el mapa
TW89GS Brentford
Ver en el mapa
65205 Wiesbaden
Ver en el mapa
2880 Bagsvaerd
Ver en el mapa
64293 Darmstadt
Ver en el mapa
55218 Ingelheim
Ver en el mapa
CT13 9NJ Sandwich
Ver en el mapa